transionalcare:...

25
4/8/15 1 Leigh Ann Ross Associate Dean of Clinical Affairs UMMC School of Pharmacy Transitional Care: How Pharmacists Can Impact Outcomes April 14, 2015 Transi(onal Care: How Pharmacists Can Impact Outcomes Leigh Ann Ross, PharmD, BCPS, FCCP, FAPhA Associate Dean for Clinical Affairs Chair, Department of Pharmacy Prac7ce The University of Mississippi School of Pharmacy BreB Smith, PharmD Clinical Instructor The University of Mississippi School of Pharmacy April 14, 2015

Upload: others

Post on 15-Aug-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: TransionalCare: HowPharmacistsCanImpactOutcomesatomalliance.org/wp-content/uploads/2015/04/IQH-Pharmacist.pdf · 4/8/15 1 Leigh Ann Ross Associate Dean of Clinical Affairs UMMC School

4/8/15

1

Leigh Ann Ross

Associate Dean of Clinical Affairs

UMMC School of Pharmacy

Transitional Care: How Pharmacists Can Impact Outcomes

April 14, 2015

 Transi(onal  Care:    

How  Pharmacists  Can  Impact  Outcomes      

Leigh  Ann  Ross,  PharmD,  BCPS,  FCCP,  FAPhA  Associate  Dean  for  Clinical  Affairs  

Chair,  Department  of  Pharmacy  Prac7ce  The  University  of  Mississippi  School  of  Pharmacy  

 BreB  Smith,  PharmD  Clinical  Instructor  

The  University  of  Mississippi  School  of  Pharmacy    

April  14,  2015        

Page 2: TransionalCare: HowPharmacistsCanImpactOutcomesatomalliance.org/wp-content/uploads/2015/04/IQH-Pharmacist.pdf · 4/8/15 1 Leigh Ann Ross Associate Dean of Clinical Affairs UMMC School

4/8/15

2

Objec(ves  •  Describe  transi7ons  of  care  (TOC)  in  various  seCngs  •  Discuss  common  medica7on  errors  seen  during  TOC  •  Explain  poten7al  pharmacist  interven7ons  during  TOC  •  Analyze  implemented  TOC  programs  and  their  outcomes  

•  Describe  the  University  of  Mississippi  School  of  Pharmacy’s  Project:    Pharmacist  Linkage  in  Care  Transi2ons:  From  Academic  Medical  Center  to  Community    

Defining  Transi(ons  of  Care  

Page 3: TransionalCare: HowPharmacistsCanImpactOutcomesatomalliance.org/wp-content/uploads/2015/04/IQH-Pharmacist.pdf · 4/8/15 1 Leigh Ann Ross Associate Dean of Clinical Affairs UMMC School

4/8/15

3

Transi(ons  of  Care  

•  “Movement  of  pa7ents  between  health  care  loca7ons,  providers,  or  different  levels  of  care  within  the  same  loca7on  as  their  condi7ons  and  care  needs  change.”  •  Na7onal  Transi7ons  of  Care  Coali7on  (NTOCC)    

•  High  risk  for  readmission,  medica7on  errors,  increased  expenses,  and  overall  diminished  quality  of  pa7ent  care  if  transi7ons  of  care  are  not  handled  appropriately.  

Types  of  Transi(ons  •  Home  to  hospital  

•  Preadmission  medica7on  reconcilia7on  •  Communica7on  with  outpa7ent  pharmacy  

•  Hospital  to  home  •  Post-­‐discharge  follow-­‐up  appointment  •  Communica7on  with  primary  care  providers  •  Discharge  medica7on  reconcilia7on  •  Discharge  medica7on  educa7on  

•  Within  hospital  •  Medica7on  reconcilia7on  and  order  review  •  Communica7on  with  transferring  interdisciplinary  team  

Page 4: TransionalCare: HowPharmacistsCanImpactOutcomesatomalliance.org/wp-content/uploads/2015/04/IQH-Pharmacist.pdf · 4/8/15 1 Leigh Ann Ross Associate Dean of Clinical Affairs UMMC School

4/8/15

4

Goals  of  Transi(ons  of  Care  •  Improve  pa7ent  care  •  Prevent  all-­‐cause  readmission  post-­‐discharge  •  Avoid  medica7on  errors  •  Increase  provider  communica7on  •  Provide  in  depth  pa7ent  educa7on  and  ensure  pa7ent  understanding  

•  Improve  pa7ent  adherence  and  compliance  •  Maximize  Medicare  and  Medicaid  reimbursement  rates  

 

Readmission    and    

Reimbursements  

Page 5: TransionalCare: HowPharmacistsCanImpactOutcomesatomalliance.org/wp-content/uploads/2015/04/IQH-Pharmacist.pdf · 4/8/15 1 Leigh Ann Ross Associate Dean of Clinical Affairs UMMC School

4/8/15

5

Readmission  Post-­‐Discharge  

•  Nearly  20%  of  Medicare  pa7ents  were  readmiYed  within  30  days  of  discharge  in  2009  •  50%  did  not  see  provider  post-­‐discharge  

•  60-­‐day  readmission  rates  were  31%  •  Readmission  rate  decline  in  2012                  Jencks  SF,  et  al.  Rehospitaliza2ons  among  Pa2ents  in  the  Medicare  Fee-­‐for-­‐Service  Program.  NEJM  2009;  360:1418-­‐1428.  Bellone  JM,  et  al.  Postdischarge  interven2ons  by  pharmacists  and  impact  on  hospital  readmission  rates.  JAPhA.  2012;52:358-­‐62.  

Page 6: TransionalCare: HowPharmacistsCanImpactOutcomesatomalliance.org/wp-content/uploads/2015/04/IQH-Pharmacist.pdf · 4/8/15 1 Leigh Ann Ross Associate Dean of Clinical Affairs UMMC School

4/8/15

6

CMS  Reimbursement  •  Hospital  Readmissions  Reduc7on  Program  

•  Affordable  Care  Act  added  to  Social  Security  Act  •  Centers  for  Medicare  &  Medicaid  Services  (CMS)  limit  reimbursement  based  on  30-­‐day  readmission  rates  

•  Acute  Myocardial  Infarc7on  (AMI),  Heart  Failure  (HF),  Pneumonia  (PN)  

•  New  applicable  condi7ons  added  in  2014  •  Acute  exacerba7on  of  chronic  obstruc7ve  pulmonary  disease  (COPD)  

•  Elec7ve  total  hip  arthroplasty  (THA)  and  total  knee  arthroplasty  (TKA)  

Page 7: TransionalCare: HowPharmacistsCanImpactOutcomesatomalliance.org/wp-content/uploads/2015/04/IQH-Pharmacist.pdf · 4/8/15 1 Leigh Ann Ross Associate Dean of Clinical Affairs UMMC School

4/8/15

7

hTp://kaiserhealthnews.org/news/medicare-­‐readmissions-­‐penal2es-­‐by-­‐state/  

Medica(on  Errors  

Page 8: TransionalCare: HowPharmacistsCanImpactOutcomesatomalliance.org/wp-content/uploads/2015/04/IQH-Pharmacist.pdf · 4/8/15 1 Leigh Ann Ross Associate Dean of Clinical Affairs UMMC School

4/8/15

8

Medica7on  Errors  •  60%  of  medica7on  errors  occur  during  transi7ons  of  care  

•  Medica7on  errors  during  within  hospital  transi7ons  •  22%  during  admission  •  66%  to  or  from  intensive  care  unity  •  12%  during  discharge  

•  80%  of  serious  medical  errors  are  caused  by  miscommunica7on  during  a  care  transi7on  

•  19%  of  Medicare  pa7ents  had  an  adverse  effect  (mostly  from  drugs)  within  3  weeks  post-­‐discharge  

Aronson  JK.  Medica2on  errors:  defini2ons  and  classifica2ons.  Br  J  Clin  Pharmacol  /  67:6  /  599–604    

Page 9: TransionalCare: HowPharmacistsCanImpactOutcomesatomalliance.org/wp-content/uploads/2015/04/IQH-Pharmacist.pdf · 4/8/15 1 Leigh Ann Ross Associate Dean of Clinical Affairs UMMC School

4/8/15

9

Types  of  Medica7on  Errors  

•  Prescribing  error  •  Error  of  omission  •  Duplica7on  •  Dosing  error  •  Drug  interac7on  •  Compliance  error  

Pharmacist  Interven(ons  

Page 10: TransionalCare: HowPharmacistsCanImpactOutcomesatomalliance.org/wp-content/uploads/2015/04/IQH-Pharmacist.pdf · 4/8/15 1 Leigh Ann Ross Associate Dean of Clinical Affairs UMMC School

4/8/15

10

Pharmacist  Interven7ons  

Pharmacist  interven7ons  can  occur  in  a(n):  •  Hospital  •  Emergency  department  •  Outpa7ent  clinic  •  Skilled  nursing  facility    •  Long-­‐term  Care  facility  •  Retail  pharmacy  •  Home  health  

Pharmacists  Role  in  TOC  •  Kern  et  al.  sent  survey  to  pharmacy  directors    

•  Medica7on  history  on  admission  completed  by  nurses  (56%)  and  pharmacy  staff  (31%)  

•  Targeted  pharmacy  service  for  specific  pa7ent  popula7on  in  25%  of  facili7es  

•  56%  reported  their  pharmacists  educated  pa7ents  on  certain  medica7ons,  and  6%  had  pharmacists  educated  on  all  new  medica7ons  

•  32%  reported  that  their  pharmacists  did  not  provide  pa7ent  educa7on  

•  On  transi7ons  within  the  hospital,  19%  had  pharmacists  involved  with  order  and  drug  selec7on,  and  43%  reported  involvement  with  medica7on  reconcilia7on  

 

Page 11: TransionalCare: HowPharmacistsCanImpactOutcomesatomalliance.org/wp-content/uploads/2015/04/IQH-Pharmacist.pdf · 4/8/15 1 Leigh Ann Ross Associate Dean of Clinical Affairs UMMC School

4/8/15

11

Medica(on  Reconcilia(on  •  “Comprehensive  evalua7on  of  a  pa7ent’s  medica7on  regimen  any  7me  there  is  a  change  in  therapy  in  an  effort  to  avoid  medica7on  errors…”  •  American  Pharmacists  Associa7on  (APhA)  and  American  Society  of  Health-­‐System  Pharmacists  (ASHP)  

•  Comple7ng  an  accurate  and  complete  medica7on  list  at  every  transi7on  of  care  

•  A  2010  study  showed  that  upon  obtaining  a  medica7on  history,  pharmacists  iden7fied  significantly  more  pre-­‐admission  medica7ons  than  physicians  

 

Page 12: TransionalCare: HowPharmacistsCanImpactOutcomesatomalliance.org/wp-content/uploads/2015/04/IQH-Pharmacist.pdf · 4/8/15 1 Leigh Ann Ross Associate Dean of Clinical Affairs UMMC School

4/8/15

12

Medica(on  Reconcilia(on  Steps  1. Comprehensive  list  of  current  medica7ons  

•  Prescrip7on,  Over-­‐the-­‐counter  medica7ons,  Vitamins  •  Dose,  frequency,  route  •  Refill  history  •  Pa7ent  adherence    

2. Create  list  of  medica7on  to  be  prescribed  •  Based  on  acute  and  chronic  condi7on  management  •  Contraindica7ons,  allergies,  and  pa7ent  preference  considered  

 

Medica(on  Reconcilia(on  Steps  3. Compare  original  and  updated  medica7on  lists  

•  Prevent  duplica7on  •  Ensure  each  condi7on  is  addressed    

4. Clinically  decide  which  medica7ons  should  be  con7nued,  discon7nued,  or  added  

 

5.  Communicate  •  Provide  recommenda7ons  to  health  care  team  •  Educate  pa7ent  about  new  regimen  

 

Page 13: TransionalCare: HowPharmacistsCanImpactOutcomesatomalliance.org/wp-content/uploads/2015/04/IQH-Pharmacist.pdf · 4/8/15 1 Leigh Ann Ross Associate Dean of Clinical Affairs UMMC School

4/8/15

13

Inpa(ent  Pa(ent  Educa(on  •  Discharge  counseling    

•  Discharge  plan  review  •  Disease  state  educa7on  •  Medica7on  regimen  review  

•  Pa7ent  educa7on  •  Specific  medica7on  educa7on  •  Demonstra7on  of  how  to  use  medica7on  (i.e.  insulin,  asthma  inhalers)  

Community  Pharmacy  •  Partnership  with  community  hospital  •  Medica7on  delivery  to  the  hospital  or  pa7ent’s  home  

•  Medica7on  management  post-­‐discharge  •  Pa7ent  follow-­‐up  within  72  hours  post-­‐discharge  

•  Opportunity  for  Medica7on  Therapy  Management  services  •  Pa7ent  appointment  with  pharmacist  for  medica7on  review  and  educa7on  

•  Transi7ons  of  Care  call  centers  

Page 14: TransionalCare: HowPharmacistsCanImpactOutcomesatomalliance.org/wp-content/uploads/2015/04/IQH-Pharmacist.pdf · 4/8/15 1 Leigh Ann Ross Associate Dean of Clinical Affairs UMMC School

4/8/15

14

Nursing  Facili(es  •  Consultant  pharmacist  required  by  CMS  at  some  long-­‐term  care  facili7es  

•  Monthly  medica7on  review  •  Telephone  follow-­‐up  1  week  post-­‐discharge  •  Communica7on  with  physicians  regarding  medica7on  discrepancies  

•  Communica7on  with  pa7ent  and  caregivers  regarding  medica7on  regimen  

•  Transi7ons  of  Care  call  centers  

Ambulatory  Care  •  Postacute  care  clinic  (PACC)  model  

•  Interdisciplinary  team  follow-­‐up  in  an  outpa7ent  seCng  post-­‐discharge  

•  Pharmacist  reviews  medica7on  changes,  evaluates  for  appropriate  use,  and  facili7es  communica7on  between  providers  

•  Scheduling  and  7me  constraints  are  barriers  

Page 15: TransionalCare: HowPharmacistsCanImpactOutcomesatomalliance.org/wp-content/uploads/2015/04/IQH-Pharmacist.pdf · 4/8/15 1 Leigh Ann Ross Associate Dean of Clinical Affairs UMMC School

4/8/15

15

Pharmacist  TOC  Interven(on  Studies  •  University  of  New  Mexico  Hospital  pharmacy-­‐driven  Care  Transi7ons  Service  (CTS)  impact  on  medica7on  related  problems  

•  CTS  phases  1. Medica7on  reconcilia7on  2.  Discharge  medica7on  review  and  hospital-­‐to-­‐community  

pharmacist  handoff  3.  Follow-­‐up  phone  call  within  72  hours  of  discharge  4.  Outpa7ent  medica7on  reconcilia7on  at  post-­‐discharge  

appointment    

Conklin  JR,  Togami  JC,  BurneT  A,  Dodd  MA,  Ray  GM.  Care  transi2ons  service:  a  pharmacy-­‐driven  program  for  medica2on  reconcilia2on  through  the  con2nuum  of  care.  AJHP.  2014;71:802-­‐10.    

Pharmacist  TOC  Interven(on  Studies  cont.  

•  1140  MRPs  iden7fied  during  phase  1  aker  admiCng  team  performed  medica7on  reconcilia7on  

•  70%  of  MRPs  were  resolved  through  pharmacy  interven7on  independent  of  provider  

•  Interven7ons  involved  removal  (43%)  and  addi7on  (29%)  of  medica7ons  

       Conklin  JR,  Togami  JC,  BurneT  A,  Dodd  MA,  Ray  GM.  Care  transi2ons  service:  a  pharmacy-­‐driven  program  for  medica2on  reconcilia2on  through  the  con2nuum  of  care.  AJHP.  2014;71:802-­‐10.    

Page 16: TransionalCare: HowPharmacistsCanImpactOutcomesatomalliance.org/wp-content/uploads/2015/04/IQH-Pharmacist.pdf · 4/8/15 1 Leigh Ann Ross Associate Dean of Clinical Affairs UMMC School

4/8/15

16

Pharmacist  TOC  Interven(on  Studies    •  Union  Memorial  Hospital  in  Bal7more  –  Chart  Review  •  Comparing  internal  medicine  pa7ents  who  received  pharmacy  discharge  counseling  versus  standard  discharge  process  

•  228  of  1136  discharged  pa7ents  received  counseling  •  No  difference  in  30  day  readmission  rates  between  groups  

•  Stra7fied  based  on  readmission  risk  •  Moderate-­‐risk  group  with  counseling  had  significantly  lower  readmission  rate  (3.8%  vs.  18.9%)  

•  High-­‐risk  pa7ents  ini7ally  targeted  for  counseling  services        

S2ll  KL,  Davis  AK,  Chilipko  AA,  Jenkosol  A,  Norwood  DK.  Evalua2on  of  a  pharmacy-­‐driven  inpa2ent  discharge  counseling  service:  impact  on  30-­‐day  readmission  rates.  Consult  Pharm.  2013;28(12):775-­‐85    

Pharmacist  TOC  Interven(on  Studies    •  Prospec7ve,  randomized,  pilot  study  •  Effect  of  pharmacy  clinic  visit  post-­‐discharge  on  readmission,  ED  visits,  and  medica7on  discrepancy  resolu7on  

•  54%  had  medica7on  discrepancies  iden7fied  (n=33)  –  50%  resolved  in  interven7on  group  –  9.5%  resolved  in  usual  care  group  

•  Lower  30-­‐day  rehospitaliza7on  and  ED  visit  composite  outcome  in  interven7on  vs.  usual  care  group  (0%  vs.  40.5%)  

Hawes  EM,  Maxwell  WD,  White  SF,  Mangun  J,  Lin  FC.  Impact  of  an  outpa2ent  pharmacist  interven2on  on  medica2on  discrepancies  and  health  care  resource  u2liza2on  in  posthospitaliza2on  care  transi2ons.  J  Prim  Care  Community  Health.  2014;5(1):14-­‐8.    

Page 17: TransionalCare: HowPharmacistsCanImpactOutcomesatomalliance.org/wp-content/uploads/2015/04/IQH-Pharmacist.pdf · 4/8/15 1 Leigh Ann Ross Associate Dean of Clinical Affairs UMMC School

4/8/15

17

Pharmacist  TOC  Interven(on  Studies    •  CommUnityCare  and  Seton  University  Medical  Center  at  Brackenridge  in  Aus7n,  TX  –  Retrospec7ve  EHR  review  

•  60  day  readmission  with  pharmacist  interven7on  within  60  days  post-­‐discharge  (n=67)  vs.  no  interven7on  (n=67)  

•  Pharmacist  interven7on  •  Drug  therapy  ini7a7on  or  discon7nua7on    •  Dosage  adjustment  (52%)  •  Pa7ent  counseling  (88%)  •  Laboratory  monitoring  

•  Interven7on  group  had  significantly  lower  60  day  readmission  rates  compared  to  control  (18%  vs.  43%)  

     Bellone  2012  JAPhA    

Pharmacist  TOC  Interven(on  Studies    •  Medica7on  reconcilia7on  in  a  long-­‐term  care  facility  

•  CroYy  et  al.  inves7gated  pharmacist  impact  on  transi7on  from  hospital  to  long-­‐term  care  facility  •  U7lized  the  Medica7on  Appropriateness  Index  (MAI)  score  

•  Assessment  for  older  adults  

–  Improvement  in  medica7on  appropriateness  when  a  pharmacist  performed  a  medica7on  review  (n=56)  versus  control  (n=54)  

 CroTy  M,  et  al.  Does  the  addi2on  of  pharmacist  transi2on  coordinator  improve  evidence-­‐based  medica2on  management  and  health  outcomes  in  older  adults  moving  from  the  hospital  to  a  long-­‐term  care  facility?  Results  of  a  randomized,  controlled  trial.  Am  J  Geriatr  Pharmacother  2004;2:257-­‐64.        

ü  Indica7on  ü  Effec7veness  ü  Dose  ü  Direc7ons  ü  Prac7ce  direc7ons  ü  Drug-­‐drug  interac7ons  ü  Drug-­‐disease  

interac7ons  ü  Cost  ü  Unnecessary  

duplica7on  ü  Dura7on  of  therapy  

Page 18: TransionalCare: HowPharmacistsCanImpactOutcomesatomalliance.org/wp-content/uploads/2015/04/IQH-Pharmacist.pdf · 4/8/15 1 Leigh Ann Ross Associate Dean of Clinical Affairs UMMC School

4/8/15

18

Pharmacist  TOC  Interven(on  Studies    •  Telephone  follow-­‐up  within  48  hours  (n=110)  versus  control  group  (n=111)  

•  Discussed  hospital  stay,  follow-­‐up  appointments,  medica7ons  –  Addressed  any  problems  –  Communica7on  with  inpa7ent  medical  team  if  needed  

•  Significantly  less  likely  to  have  an  emergency  department  visit  within  30  days  compared  to  control  (10%  vs.  24%)  

•  86%  of  pa7ents  reported  being  very  sa7sfied  with  medica7on  instruc7on  vs.  61%  in  the  control  group  

       Dudas  V,  Bookwalter  T,  Kerr  KM,  Pan2lat  SZ.  The  impact  of  follow-­‐up  telephone  calls  to  pa2ents  afer  hospitaliza2on.  Am  J  Med.  2001;111:26-­‐30S.    

Transi(ons  of  Care    Models  and  Resources  

Page 19: TransionalCare: HowPharmacistsCanImpactOutcomesatomalliance.org/wp-content/uploads/2015/04/IQH-Pharmacist.pdf · 4/8/15 1 Leigh Ann Ross Associate Dean of Clinical Affairs UMMC School

4/8/15

19

Re-­‐engineered  Discharge  (RED)  •  Boston  University  Medical  Center  •  Clinical  pharmacist  involvement  •  Discharge  medica7on  reconcilia7on  •  Appointments  for  follow-­‐up  •  Medical  appointments  and  laboratory  tests  •  Discharge  summary  transmission  to  outside  provider  •  Post-­‐discharge  telephone  calls  

Re-­‐engineered  Discharge  (RED)  •  749  general  hospital  pa7ents  over  18  •  Nurse  discharge  advocate  

•  Follow-­‐up  appointment  scheduling  •  Pa7ent  educa7on  •  Medica7on  reconcilia7on  

•  Clinical  pharmacist  •  Telephone  follow-­‐up  within  2-­‐4  days  post-­‐discharge  

•  Decreased  ED  visits  and  hospitaliza7ons  within  30  days  post-­‐discharge  with  interven7on  

Page 20: TransionalCare: HowPharmacistsCanImpactOutcomesatomalliance.org/wp-content/uploads/2015/04/IQH-Pharmacist.pdf · 4/8/15 1 Leigh Ann Ross Associate Dean of Clinical Affairs UMMC School

4/8/15

20

Care  Transi(ons  Interven(on  (CTI)  •  Self-­‐management  focus  •  Transi7ons  coach  helps  pa7ent  with  communica7on  skills,  confidence,  and  behaviors  

•  Home  visit  and  3  telephone  calls  post-­‐discharge  •  Medica7on  management,  personal  health  record,  follow-­‐up  with  providers,  and  pa7ent  recogni7on  of  symptoms  requiring  follow-­‐up  

Hospital  to  Home  (H2H)  •  American  College  of  Cardiology  and  the  Ins7tute  for  Healthcare  Improvement  

•  Quality  improvement  ini7a7ve  •  Improve  transi7ons  of  care  to  reduce  readmissions  for  pa7ents  with  HF  or  AMI  

•  Goal:  20%  rela7ve  reduc7on  in  CMS  30-­‐day  all-­‐cause  readmission  rate  

•  Clearing  house  for  resources,  tools,  and  strategies  for  enrolled  par7cipants  

Page 21: TransionalCare: HowPharmacistsCanImpactOutcomesatomalliance.org/wp-content/uploads/2015/04/IQH-Pharmacist.pdf · 4/8/15 1 Leigh Ann Ross Associate Dean of Clinical Affairs UMMC School

4/8/15

21

BeBer  Outcomes  for  Older  Adults  through  Safe  Transi(ons  

•  Risk  assessment  tool    •  8  Ps  (problem  medica7on,  psychological,  principal  diagnosis,  polypharmacy,  poor  healthy  literacy,  pa7ent  support,  prior  hospitaliza7on,  pallia7ve  care)  

•  Helps  to  determine  risk  of  adverse  events  during  transi7ons  of  care  

 

Pharmacist  Linkage  in  Care  Transi(ons  Project:  From  Academic  

Medical  Center  to  Community      

The National Association of Chain Drug Stores Foundation is gratefully acknowledged for their support

Page 22: TransionalCare: HowPharmacistsCanImpactOutcomesatomalliance.org/wp-content/uploads/2015/04/IQH-Pharmacist.pdf · 4/8/15 1 Leigh Ann Ross Associate Dean of Clinical Affairs UMMC School

4/8/15

22

UM  SOP  Transi(ons  of  Care  Project  •  Partnership  between  University  of  Mississippi  School  of  Pharmacy,  University  of  Mississippi  Medical  Center,  Walgreens,  and  the  Mississippi  Division  of  Medicaid  

UM  SOP  Transi(ons  of  Care  Project  Study  Aim  

•  To  improve  pa7ent  care  through  integra7on  of  care  by  inpa7ent  and  community-­‐based  pharmacists  and  providers  during  and  post-­‐discharge  

Page 23: TransionalCare: HowPharmacistsCanImpactOutcomesatomalliance.org/wp-content/uploads/2015/04/IQH-Pharmacist.pdf · 4/8/15 1 Leigh Ann Ross Associate Dean of Clinical Affairs UMMC School

4/8/15

23

UM  SOP  Transi(ons  of  Care  Project  Inclusion  Criteria  

•  Pa7ent  admiYed  with  primary  diagnosis  of  •  Myocardial  infarc7on  •  Heart  failure  •  Pneumonia  •  Solid  Organ  Transplant  

•  Primary  pharmacy    •  Walgreens  within  60  mile  radius  of  Jackson  •  UMMC  outpa7ent  pharmacy  (Meds  &  Threads,  Pavilion,  Jackson  Medical  Mall)  

•  Included  coun7es:  Claiborne,  Hinds,  Simpson,  Madison,  Rankin,  Yazoo,  Copiah,  and  Warren  

UM  SOP  Transi(ons  of  Care  Project    Methods:  Inpa(ent  

•  Medica7on  reconcilia7on  •  In  addi7on  to  usual  med  history  performed  by  admiCng  team  and  nursing  staff  

•  Discrepancies  communicated  to  primary  care  area  pharmacist,  medical  team,  or  social  work  as  necessary    

•  Discharge  educa7on  •  Medica7on  regimen  counseling  •  Follow-­‐up  appointment  schedule  

•  Bedside  delivery  of  30  day  supply  of  discharge  medica7ons  

Page 24: TransionalCare: HowPharmacistsCanImpactOutcomesatomalliance.org/wp-content/uploads/2015/04/IQH-Pharmacist.pdf · 4/8/15 1 Leigh Ann Ross Associate Dean of Clinical Affairs UMMC School

4/8/15

24

UM  SOP  Transi(ons  of  Care  Project    Methods:  Outpa(ent  

•  Walgreens  Well-­‐Transi7ons  •  Pharmacists  perform  follow-­‐up  phone  calls  at  48  hours,  10  days,  and  25  days  post-­‐discharge  

•  Medica7on  review  •  Disease  state  symptom  resolu7on  •  Based  on  discharge  plan  sent  from  Transi7ons  of  Care  Coordinator  

•  School  of  Pharmacy  and  Walgreens  pharmacist  Medica7on  Therapy  Management  •  Face-­‐to-­‐face  visits  at  4-­‐7  days,  90  days,  and  270  days  post-­‐discharge  

•  Telephone  follow-­‐up  at  180  and  365  days  post-­‐discharge  

UM  SOP  Transi(ons  of  Care  Project    Study  Outcomes  

•  Primary  outcome:  30  day  readmission  rates  •  Secondary  outcomes  

•  60  and  90  day  readmission  rates  •  Medica7on  adherence  to  chronic  medica7ons  •  Humanis7c  outcomes  

•  Pa7ent  quality  of  life  •  Pa7ent  and  provider  sa7sfac7on  

Page 25: TransionalCare: HowPharmacistsCanImpactOutcomesatomalliance.org/wp-content/uploads/2015/04/IQH-Pharmacist.pdf · 4/8/15 1 Leigh Ann Ross Associate Dean of Clinical Affairs UMMC School

4/8/15

25

 Transi(onal  Care:    

How  Pharmacists  Can  Impact  Outcomes      

Leigh  Ann  Ross,  PharmD,  BCPS,  FCCP,  FASHP  Associate  Dean  for  Clinical  Affairs  

Chair,  Department  of  Pharmacy  Prac7ce  The  University  of  Mississippi  School  of  Pharmacy  

 BreB  Smith,  PharmD  Clinical  Instructor  

The  University  of  Mississippi  School  of  Pharmacy    

April  14,  2015        

Thank You

50

For more information contact your state’s QIN-QIO representative:

This material was presented on behalf of atom Alliance, the Quality Innovation Network-Quality Improvement Organization (QIN-QIO), coordinated by Qsource for Tennessee, Kentucky, Indiana, Mississippi and Alabama under a contract with the Centers for Medicare & Medicaid Services (CMS), a federal agency of the U.S. Department of Health and Human Services. Content does not necessarily reflect CMS policy. 15.SS.MS.02.001C